Federation of European Pharmacological Societies

Last updated

The Federation of European Pharmacological Societies (EPHAR) [1] is a non-profit voluntary association established to advance research and education in the science of pharmacology and to promote co-operation between national/regional pharmacological societies in Europe and surrounding countries. It is an umbrella organization of currently 29 national societies for pharmacology and represents over 12,000 individual pharmacologists in Europe. Moreover it seeks to co-operate with other international organizations, especially the International Union of Basic and Clinical Pharmacology (IUPHAR) of which EPHAR is an associate member. [2]

Contents

History

The efforts in the 1990s to unite European economical and political forces had found their counterpart in formation of European scientific federations. One of those scientific federations is EPHAR that was founded at the XIth International Congress of Pharmacology in Amsterdam (The Netherlands) in 1990. The establishment of the federation was prepared by a steering committee formed in 1988 under the initiative of Rodolfo Paoletti. The steering committee, headed by Börje Uvnäs, consisted of six members: Alasdair Breckenridge (UK), Flaminio Cattabeni (Italy), Gilles Fillion (France), Ove A. Nedergaard (Denmark), Rodolfo Paoletti (Italy), Hasso Scholz (Germany), Börje Uvnäs (Sweden). EPHAR was recognized as an affiliate member of IUPHAR in 1994. Since 1990, the Federation has sponsored important scientific events. In particular, EPHAR has contributed in the organization of residential courses with a restricted number of participants ("Molecular Biology in Pharmacology", Milan, 1990; "Neuroimmunomodulation in Pharmacology", Paris, 1992; "Electrophysiology in Pharmacology", London, 1993). [3]

Activities

Pharmacology has developed into a multifaceted discipline extending from molecular biology at the one end to clinical pharmacology at the other. [4] The necessity of collaborative efforts within all branches of biological sciences, in the development and analysis of new drugs, is the driving force of the activities of EPHAR. One challenge of this federation is the creation of new generations of pharmacologists with an analytical and broadminded attitude towards important aspects of modern medical biological sciences. [5]

The Federation seeks to achieve its objects by arranging instructional courses and training programs in matters connected with pharmacology, facilitating the exchange of scientific information between European pharmacologists (by encouraging the holding of joint meetings between European member societies), disseminating information and encouraging the participation to important activities organized by member societies. This will include the production of a calendar of the National and joint meetings of each European Society.

Another important goal of the Federation is establishing common standards for basic courses in pharmacology, and fixing minimal standards for a European Pharmacologist Certificate.

The scientific dissemination is a fundamental step in progress and advance in research and education. For this reason, the most important scientific events established by the Federation are the EPHAR Congresses. They include plenary lectures, symposia, round tables, oral and poster communications devoted to the most recent advances in pharmacology and related sciences and therefore represented the adequate forum for discussing preclinical, clinical and therapeutic data. Particular emphasis was given to the impact of biotechnologies on drug development and to the identification of novel pharmacological approaches to incurable diseases. Sessions were also held on drug development, strategies for research funding and training of pharmacologists.

The EPHAR Congresses that have taken place since EPHAR’s foundation are: [5]

EPHAR supports activities, organized by its member societies that are intended to improve the cooperation among European pharmacologists. They are traditionally

One of these activities per year, for each country, is promoted by EPHAR. Calls for applications for these EPHAR-supported activities and the guidelines for these events are announced annually.

Moreover EPHAR gives prizes to European young investigators in the field of pharmacology, the EPHAR Young Investigators Awards. So far, the following awards were given:

Executive committees

The term of the EPHAR Executive Committees is four years.

The present (2022–2026) Executive Committee is composed by the following members: [6]

Past Presidents were:

Composition

The National Societies members of EPHAR are (in alphabetical order): • Austrian Pharmacological Society (Österreichische Pharmakologische Gesellschaft) APHAR. • Belgian Society of Fundamental and Clinical Physiology and Pharmacology. Société Belge de Physiologie et de Pharmacologie Fondamentales et Cliniques. Belgisch Genootschap voor Fundamentele en Klinische Fysiologie en Farmacologie. • Association of Pharmacologists of the Federation of Bosnia and Herzegovina. Udruženje Farmakologa Federacije Bosne i Hercegovine. • British Pharmacological Society (BPS). • Bulgarian Pharmacological Society. • Croatian Pharmacological Society. Hrvatsko Društvo Farmakologa. (HDF). • Czech Society for Experimental and Clinical Pharmacology and Toxicology. Česká Společnost pro Experimentální a Klinickou Farmakologii a Toxicologii (ČSEKFT). • Danish Society for Pharmacology, Toxicology and Medicinal Chemistry. Dansk Selskab for Farmakologi, Toksikologi og Medicinalkemi (DSFTM). • Dutch Pharmacological Society. Nederlands Vereniging voor Farmacologie (NVF) • Finnish Pharmacological Society. Suomen Farmakologiyhdistys. (SFY). • French Society of Pharmacology and Therapeutics. Société Française de Pharmacologie et de Thérapeutique. (SFPT). • German Society of Pharmacology. Deutsche Gesellschaft für Pharmakologie. (DGP). • Hellenic (Greek) Society of Basic and Clinical Pharmacology. Ελληνική Εταιρεία Φαρμακαλογίας (Ellinikí Etaireía Pharmakologías). • Hungarian Society for Experimental and Clinical Pharmacology. Magyar Kisérletes és Klinikai Farmakólogiai Társaság (MFT). • Israel Society for Physiology and Pharmacology (ISPP). • Società Italiana di Farmacologia (SIF). • Latvian Society of Pharmacology. Latvijas Farmakoloģijas biedrība. (LFB). • Norwegian Society for Pharmacology and Toxicology. Norsk Selskap for Farmakologi og Toksikologi. (NSFT). • Pharmacology Society of Malta. • Polish Pharmacological Society. Polskie Towarzystwo Farmakologiczne. (PTST). • Portuguese Pharmacological Society. Sociedade Portuguesa de Farmacologia (SPF). • Russian Scientific Society of Pharmacology. • Serbian Pharmacological Society. Српско Фармаколошко Друштво / Srpsko Farmakološko Društvo (СФД / SFD). • Slovak Pharmacological Society. Slovenská Farmakologická Spoločnosť (SFaS). • Slovenian Pharmacological Society. Slovensko Društvo Farmakologov. (SDF). • Spanish Society of Pharmacology. Sociedad Española de Farmacología (SEF). • Swedish Society for Pharmacology, Clinical Pharmacology and Therapeutics. Sektionen för Läkemedelslära. • Swiss Society of Pharmacology and Toxicology. Société Suisse de Pharmacologie et de Toxicologie/ Schweizerische Gesellschaft für Pharmakologie und Toxikologie (SSPT/SGPT). • Turkish Pharmacological Society. Türk Farmakoloji Derneği (TFD).

EPHAR website: http://www.ephar.org/

The internet sites for each European pharmacological society, member of EPHAR, are hereby listed:

• Austria: http://www.aphar.at/

• Belgium: http://users.ugent.be/~jvdvoord/physiology&pharmacology/index.htm

• Croatia: http://pharma.mef.hr/

• Czech Republic: http://farmspol.cls.cz/

• Denmark https://web.archive.org/web/20130903234249/http://dsftm.dk/index.php/en/

• Netherlands: http://www.nvfarmaco.nl/

• Finland: http://www.sfy.fi/

• France: http://www.pharmacol-fr.org/

• Germany: http://www.dg-pharmakologie.de/

• Greece: https://web.archive.org/web/20131007085419/http://gsp.med.auth.gr/

• Hungary: http://www.mapharm.hu/

• Italy: http://www.sifweb.org/

• Norway: http://www.nsft.net/ Archived 2014-12-18 at the Wayback Machine

• Poland: http://www.ptf.info.pl/

• Serbia: http://www.sfarmd.org/

• Slovakia: http://www.sfarm.sk/

• Spain: http://www.socesfar.com/

• Sweden http://www.lakemedelslara.se/

• Switzerland: http://www.swisspharmtox.ch/

• Turkey: http://www.tfd.org.tr/

• United Kingdom: https://web.archive.org/web/20130410071823/http://www.bps.ac.uk/view/index.html

Related Research Articles

<span class="mw-page-title-main">Pharmacology</span> Branch of biology concerning drugs

Pharmacology is the science of medical drugs and medications, including a substance's origin, composition, pharmacokinetics, therapeutic use, and toxicology. More specifically, it is the study of the interactions that occur between a living organism and chemicals that affect normal or abnormal biochemical function. If substances have medicinal properties, they are considered pharmaceuticals.

Clinical pharmacology is "that discipline that teaches, does research, frames policy, gives information and advice about the actions and proper uses of medicines in humans and implements that knowledge in clinical practice". Clinical pharmacology is inherently a translational discipline underpinned by the basic science of pharmacology, engaged in the experimental and observational study of the disposition and effects of drugs in humans, and committed to the translation of science into evidence-based therapeutics. It has a broad scope, from the discovery of new target molecules to the effects of drug usage in whole populations. The main aim of clinical pharmacology is to generate data for optimum use of drugs and the practice of 'evidence-based medicine'.

<span class="mw-page-title-main">Robert Bosch Stiftung</span> Charitable institution in Europe

The Robert Bosch Stiftung GmbH is a German foundation that owns a majority shareholding in Robert Bosch GmbH, from which it derives its funding. The foundation was established in accordance with the wishes of Robert Bosch, who died in 1942, and conducts and finances social, cultural and scientific projects.

The International Union of Basic and Clinical Pharmacology (IUPHAR) is a voluntary, non-profit association representing the interests of scientists in pharmacology-related fields to facilitate Better Medicines through Global Education and Research around the world.

Monika Schäfer-Korting is a German Pharmacologist and Toxicologist.

<span class="mw-page-title-main">British Pharmacological Society</span> British society of pharmacologists

The British Pharmacological Society is the primary UK learned society for pharmacologists, concerned with research into drugs and the ways in which they work. Members work in academia, industry, regulatory agencies, and the health services, and many are medically qualified. The Society covers the whole spectrum of pharmacology, including laboratory, clinical, and toxicological aspects.

Sava Dumitrescu was a Romanian pharmacologist and professor at the Grigore T. Popa University of Medicine and Pharmacy in Iaşi, Romania. He also served as rector of the university. He retired from teaching in 1993, but continued his research activities.

The American Society for Pharmacology and Experimental Therapeutics (ASPET) is a scientific society founded in late 1908 by John Jacob Abel of Johns Hopkins University, with the aim of promoting the growth of pharmacological research. Many society members are researchers in basic and clinical pharmacology who help develop disease-fighting medications and therapeutics. ASPET is one of the constituent societies of the Federation of American Societies for Experimental Biology (FASEB). The society's headquarters are in Rockville, MD. The current president is Michael F. Jarvis.

Anton Gordonoff was a Swiss pharmacologist and toxicologist of Russian origin.

<span class="mw-page-title-main">Ulrich Förstermann</span>

Ulrich Förstermann is a German physician and pharmacologist.

Gabriel Leon "Gabbie" Plaa was an American-Canadian toxicologist. A specialist of hepatotoxicity, he held various administrative position at Université de Montréal from 1968 to 1989, receiving the grade of professor emeritus upon his retirement in 1996. Over the course of his career he was president of several scientific society and served in editorial capacity for numerous scientific journals. Amongst many awards, he was the first recipient of the Society of Toxicology's (SOT) Achievement Award, an award granted to a "promising young scientist".

Donald Robert James Singer was a British clinical pharmacologist who was the president of the Fellowship of Postgraduate Medicine.

<span class="mw-page-title-main">European Association for Clinical Pharmacology and Therapeutics</span>

The European Association for Clinical Pharmacology and Therapeutics (EACPT) is a learned society in the field of clinical pharmacology. It is the leading society in Europe serving the European and global Clinical Pharmacology and Therapeutics community. It has its origins in a working party in the early 1980s under the auspices of the World Health Organization (WHO-Europe). Subsequently, a committee was created in 1993 chaired by Folke Sjöqvist with the remit to prepare the first congress of EACPT, held in Paris in 1995. At that congress the founding EACPT Council elected an Executive Committee with Sjöqvist as chairman, Michael Orme as Honorary Secretary, Jochen Kuhlmann (Germany) as Treasurer, and Giampaolo Velo (Italy) as Vice-Chairman, with 26 European countries as members through their home country clinical pharmacology society or section. The EACPT now includes all national organisations for clinical pharmacology in Europe and provides educational and scientific support for the more than 4000 individual professionals interested in Clinical Pharmacology and Therapeutics throughout the European region, with its congresses attended by a global audience.

<span class="mw-page-title-main">László Szekeres</span>

László Szekeres. Professor Emeritus, Institute of Pharmacology and Therapeutics, Medical Faculty of the University of Szeged, Hungary. He has held a number of notable positions and received a number of awards. His research contributed to the development of cardiac drugs.

William Douglas Figg is an American scientist (pharmacologist). He is a senior investigator (tenured) at the National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, Maryland. He holds multiple titles within the NCI: Associate Director of the Center for Cancer Research, Co-Director of the Office of Translational Resources, Acting Branch Chief for the Genitourinary Malignancies Branch, Chief of the Clinical Pharmacology Program, and head of the Molecular Pharmacology Section. Figg is also the Co-chief of Basic Research at the Center for Prostate Disease Research within the Walter Reed National Military Medical Center – Murtha Cancer Center in Bethesda, Maryland.

The IUPHAR/BPS Guide to PHARMACOLOGY is an open-access website, acting as a portal to information on the biological targets of licensed drugs and other small molecules. The Guide to PHARMACOLOGY is developed as a joint venture between the International Union of Basic and Clinical Pharmacology (IUPHAR) and the British Pharmacological Society (BPS). This replaces and expands upon the original 2009 IUPHAR Database. The Guide to PHARMACOLOGY aims to provide a concise overview of all pharmacological targets, accessible to all members of the scientific and clinical communities and the interested public, with links to details on a selected set of targets. The information featured includes pharmacological data, target, and gene nomenclature, as well as curated chemical information for ligands. Overviews and commentaries on each target family are included, with links to key references.

The Association for Ocular Pharmacology and Therapeutics (AOPT) is an organization that welcomes members from disciplines related to ocular pharmacology and its therapeutic applications. The mission of AOPT is the sustenance of a scientific network aiming the dissemination of knowledge in the field of ocular disease, pharmacology and therapeutics.

<span class="mw-page-title-main">Filippo Drago (pharmacologist)</span> Italian pharmacologist, neurologist, and psychiatrist

Filippo Drago is an Italian pharmacologist, neurologist and psychiatrist.

Rohini Kuner is an Indian-born German pharmacologist and director of the Institute of Pharmacology at Heidelberg University.

<span class="mw-page-title-main">Otto Krayer</span>

Otto Hermann Krayer was a German-American physician, pharmacologist and university professor.

References

  1. "EPHAR The Federation of European Pharmacological Societies"
  2. "IUPHAR Associate Members Archived 2011-11-05 at the Wayback Machine "
  3. "History of EPHAR"
  4. U. Förstermann and T. Griesbacher: "The edge of glory [ permanent dead link ]". Public Service Review: European Science & Technology, 2012, 15: pp.222−223
  5. 1 2 U. Förstermann: "Pharmacology across Europe, a status report Archived 2014-07-22 at the Wayback Machine " Pharmacology Matters, 2012, vol.5(2), pp.6−9.
  6. "EPHAR Executive Committee Archived 2015-09-08 at the Wayback Machine "